SYDENHAM Laboratories, Inc.
Mark Angelo Coz has extensive experience in sales and marketing within the healthcare sector. Currently serving as the Sales and Marketing Manager at SYDENHAM Laboratories, Inc. since 2017, Mark has previously held key positions such as Division Manager for Pedia/OB/Infant Nutrition at Pacific Healthcare Group of Companies from January 2016 to April 2017, and National Sales Manager at Vamsler Philippines Inc. from 2010 to 2015. In earlier roles, Mark contributed as Marketing Manager and Regional Sales Manager at InnoGen-Vamsler, as well as District Sales Manager at Innogen-Vamsler Philippines Inc. Mark holds a Bachelor of Science in Physical Therapy from Emilio Aguinaldo College, completed in 1998.
This person is not in any offices
SYDENHAM Laboratories, Inc.
Sydenham Laboratories, Inc. (SLI) is an ISO 9001:2008, HACCP Certified, PIC/s GMP compliant pharmaceutical company that develops and manufactures healthcare products. SLI manufactures oral drug preparations in dosage forms of tablet, capsule, syrup, and powder for suspension. Non-penicillin, penicillin and cephalexin-based products are manufactured in separate buildings with 'clean room hepa-filtered' exclusive air-handling systems to ensure zero-cross contamination. SLI also manufactures food supplements in the above dosage forms. SLI is founded in 1971 by Dr. Eduardo R. dela Cruz, MD, a cardiologist and a former president of Philippine Medical Association. SLI derived its name from one of the great British physicians, Dr. Thomas Sydenham, known as the English Hippocrates, the founder of clinical medicine, and an advocate of effective management of illness that emphasized detailed observation and maintained patient records.